Clinical Trials Directory

Trials / Conditions / Stage IIB Pancreatic Cancer AJCC v8

Stage IIB Pancreatic Cancer AJCC v8

12 registered clinical trials studyying Stage IIB Pancreatic Cancer AJCC v8 — 1 currently recruiting.

StatusTrialSponsorPhase
Active Not RecruitingCalaspargase Pegol-Mnkl and Cobimetinib for the Treatment of Locally Advanced or Metastatic Pancreatic Cancer
NCT05034627
OHSU Knight Cancer InstitutePhase 1
Active Not RecruitingSonoporation and Chemotherapy for the Treatment of Pancreatic Cancer
NCT04821284
Flemming ForsbergPhase 1 / Phase 2
Active Not RecruitingGemcitabine, Nab-paclitaxel, Durvalumab, and Oleclumab Before Surgery for the Treatment of in Resectable/Borde
NCT04940286
M.D. Anderson Cancer CenterPhase 2
Active Not RecruitingA Study to Determine if the Drug, Pyrvinium Pamoate, is Safe and Tolerable in Patients With Pancreatic Cancer
NCT05055323
Thomas Jefferson UniversityPhase 1
RecruitingLenvatinib and Pembrolizumab Maintenance Therapy for the Treatment of Patients of Advanced Unresectable Pancre
NCT04887805
City of Hope Medical CenterPhase 2
Active Not RecruitingA Vaccine (Ad5.F35-hGCC-PADRE) for the Treatment of Gastrointestinal Adenocarcinoma
NCT04111172
Thomas Jefferson UniversityPhase 2
WithdrawnTesting a New Anti-cancer Drug Combination, Entinostat and GSK525762C, for Advanced and Refractory Solid Tumor
NCT03925428
National Cancer Institute (NCI)Phase 1
CompletedReal-Time Monitoring of Chemotherapy Side-Effects in Patients With Gastrointestinal Cancers, RT-CAMSS Study
NCT04449679
Thomas Jefferson UniversityN/A
Active Not RecruitingLosartan and Hypofractionated Rx After Chemo for Tx of Borderline Resectable or Locally Advanced Unresectable
NCT04106856
University of UtahPhase 1
WithdrawnEpacadostat and Pembrolizumab in Treating Participants With Advanced Pancreatic Cancer
NCT03432676
M.D. Anderson Cancer CenterPhase 2
CompletedA Phase I Study of SOR-C13 in Patients With Advanced Solid Tumors
NCT03784677
M.D. Anderson Cancer CenterPhase 1
CompletedIACS-010759 in Advanced Cancers
NCT03291938
M.D. Anderson Cancer CenterPhase 1